Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Monday, 4 June 2018
Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial
Arun Azad
et al.
published in the
Journal of Hematology & Oncology
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment